## **Core Concept**
Pancuronium and tubocurarine are both non-depolarizing neuromuscular blockers used in anesthesia to facilitate endotracheal intubation and provide muscle relaxation during surgery. They act by competitively inhibiting the action of acetylcholine at the nicotinic receptors on the muscle endplate. However, they have different pharmacokinetic and pharmacodynamic profiles.

## **Why the Correct Answer is Right**
Pancuronium is a long-acting non-depolarizing neuromuscular blocker, whereas tubocurarine has an intermediate duration of action. A key difference between pancuronium and tubocurarine is their mechanism of elimination and their effects on the autonomic nervous system. Pancuronium is primarily eliminated by the liver and kidneys, and it has a significant autonomic blocking effect, particularly vagolytic (anticholinergic) effects. Tubocurarine, on the other hand, is primarily eliminated by the kidneys and has more pronounced histamine-releasing effects, which can lead to hypotension and tachycardia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while both drugs can cause histamine release, pancuronium is less likely to cause significant histamine release compared to tubocurarine.
- **Option B:** This option is incorrect as both drugs do not have a similar effect on the autonomic nervous system; pancuronium has more pronounced vagolytic effects.
- **Option C:** This option might seem plausible but is not the most accurate distinction; both drugs can affect blood pressure, but through different mechanisms.
- **Option D:** This option is incorrect because it does not accurately reflect a key difference between pancuronium and tubocurarine.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that pancuronium has a longer duration of action compared to tubocurarine, making it suitable for procedures requiring prolonged muscle relaxation. Additionally, its vagolytic effects can lead to tachycardia, which is an important consideration in patients with cardiovascular disease.

## **Correct Answer:** C. Pancuronium has a longer duration of action.